Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Arca Biopharma Inc
(NQ:
ABIO
)
4.120
USD
+0.140 (+3.52%)
Official Closing Price
Updated: 7:59 PM EST, Mar 5, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,937,400
Open
4.010
Bid (Size)
4.040 (1)
Ask (Size)
4.110 (3)
Prev. Close
3.980
Today's Range
3.520 - 4.150
52wk Range
2.210 - 22.00
Shares Outstanding
13,923,825
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
ARCA biopharma Announces First Patients Enrolled in ASPEN-COVID-19 Phase 2b Clinical Trial Evaluating rNAPc2 (AB201) as a Potential Treatment for COVID-19
December 15, 2020
From
GlobeNewswire News Releases
Best Penny Stocks To Buy Right Now? 5 For Your January Watch List
January 19, 2021
Tags
Market News
From
Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Performance
YTD
-0.96%
-0.96%
1 Month
-11.59%
-11.59%
3 Month
+0.73%
+0.73%
6 Month
-5.50%
-5.50%
1 Year
+8.42%
+8.42%
More News
Read More
ARCA biopharma Announces Location Change for 2020 Annual Meeting of Stockholders
December 09, 2020
From
GlobeNewswire News Releases
Looking For Penny Stocks To Buy Now? 4 Biotech Stocks To Watch
December 21, 2020
Tags
Market News
From
Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
AB201 Development as a Potential Treatment for COVID-19 Receives U.S. FDA Fast Track Designation
November 23, 2020
From
GlobeNewswire News Releases
ARCA biopharma Announces Third Quarter 2020 Financial Results and Provides Corporate Update
November 02, 2020
From
GlobeNewswire News Releases
ARCA biopharma Announces FDA Approval of IND Application for AB201 as a Potential Treatment for COVID-19
October 07, 2020
From
GlobeNewswire News Releases
ARCA biopharma Announces Promotion of Chief Medical Officer and Vice President, Regulatory Affairs & Quality
October 05, 2020
From
GlobeNewswire News Releases
ARCA biopharma Announces Submission of IND Application to U.S. FDA for AB201 as a Potential Treatment for COVID-19
September 21, 2020
From
GlobeNewswire News Releases
ARCA Biopharma Announces Completion of FDA Pre-IND Consultation Under Coronavirus Treatment Acceleration Program for AB201 as a Potential Treatment for Severe COVID-19
August 12, 2020
From
ACCESSWIRE
First Week of ABIO April 16th Options Trading
February 23, 2021
Tags
Stocks
From
Market News Video
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.